S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

VRDN Viridian Therapeutics Inc

12.36

0.42 (3.52%)

May 31 2024 - Closed

Delayed by 15 minutes

Form 3 - Initial statement of beneficial ownership of securities

Viridian Therapeutics (NASDAQ:VRDN)
Historical Stock Chart
From May 2024 to Jun 2024

Click Here for more Viridian Therapeutics Charts.

Viridian Therapeutics (NASDAQ:VRDN)
Historical Stock Chart
From Jun 2023 to Jun 2024

Click Here for more Viridian Therapeutics Charts.

Viridian Therapeutics Inc News

Viridian Therapeutics Announces Participation in Upcoming June Investor Conferences
Friday 31 May 2024 (2 days ago) • Business Wire

Viridian Therapeutics to Participate in Upcoming May Investor Conferences
Friday 10 May 2024 (3 weeks ago) • Business Wire

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 8 May 2024 (4 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 8 May 2024 (4 weeks ago) • Edgar (US Regulatory)

Viridian Therapeutics Highlights Recent Progress and Reports First Quarter 2024 Financial Results
Wednesday 8 May 2024 (4 weeks ago) • Business Wire

Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Friday 3 May 2024 (4 weeks ago) • Business Wire

Viridian Therapeutics to Webcast First Quarter 2024 Financial Results on May 8, 2024
Monday 29 April 2024 (1 month ago) • Business Wire

Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Thursday 4 April 2024 (2 months ago) • Business Wire

Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Wednesday 6 March 2024 (3 months ago) • Business Wire

Viridian Therapeutics to Participate in the Leerink Partners Global Biopharma Conference
Tuesday 5 March 2024 (3 months ago) • Business Wire

Form S-8 - Securities to be offered to employees in employee benefit plans
Wednesday 28 February 2024 (3 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 27 February 2024 (3 months ago) • Edgar (US Regulatory)

More Viridian Therapeutics Inc News Articles

SugarBud Craft Growers

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions